Sagimet Biosciences (SGMT) - News Mentions

Sign up to add (SGMT) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 2 50%
Gilead Sciences
Gilead Sciences
GILD		 1 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Sagimet Biosciences (NASDAQ:SGMT) Upgraded at Wall Street Zen
September 21
Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Recommendation of “Buy” by Brokerages
September 19
Sagimet Biosciences reports data from Phase 3 trial on denifanstat
September 17
Wall Street Zen Downgrades Sagimet Biosciences (NASDAQ:SGMT) to Sell
September 12
Trexquant Investment LP Invests $85,000 in Sagimet Biosciences Inc. $SGMT
September 11
Sagimet Biosciences announces presentations at MASH Drug Development Summit
September 10
Sagimet Biosciences Announces Upcoming Presentations at 9th Annual MASH Drug Development Summit
September 10
American Century Companies Inc. Grows Holdings in Sagimet Biosciences Inc. $SGMT
September 8
Sagimet Biosciences Inc. (SGMT) Presents At Cantor Global Healthcare Conference 2025 Transcript
September 7
Wall Street Zen Upgrades Sagimet Biosciences (NASDAQ:SGMT) to “Hold”
September 5
Sagimet Biosciences: Strong Denifanstat Pipeline Progress, Funding Overhang Keeps Stock At Hold
August 30
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
August 26
Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Consensus Rating of “Buy” by Analysts
August 20
LB Pharmaceuticals Strengthens Board of Directors with Appointments of William Kane and Rekha Hemrajani
September 25
Positive Phase 3 Results for Denifanstat for the Treatment of Moderate to Severe Acne to be Presented at the EADV Congress 2025 by Partner Ascletis
September 17
Tracking Baker Brothers Portfolio - Q2 2025 Update
September 15

Month over Month

Est. daily news mentions.

Sep 2025 0
Aug 2025 0
Jul 2025 0
Jun 2025 0
May 2025 0

How often is Sagimet Biosciences mentioned in the news?

Sagimet Biosciences was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Sagimet Biosciences performing compared to its industry peers?

Sagimet Biosciences underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Sagimet Biosciences in the last month?

There has been no significant change in the number of news mentions for Sagimet Biosciences' compared to the last month.

Why is it important to track news mentions for Sagimet Biosciences?

By monitoring mentions in the news for Sagimet Biosciences, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Sagimet Biosciences, ultimately improving their investment strategies.

Sign up and get more insights on Sagimet Biosciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
House & Congress Trading
Earnings Calendar
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.